These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 26828202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

  • 3. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.
    Nature; 1998 Feb 19; 391(6669):795-9. PubMed ID: 9486650
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K.
    Eur J Immunol; 2004 Jan 19; 34(1):81-90. PubMed ID: 14971033
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts.
    Zeddou M, Rahmouni S, Vandamme A, Jacobs N, Frippiat F, Leonard P, Schaaf-Lafontaine N, Vaira D, Boniver J, Moutschen M.
    Retrovirology; 2007 Oct 10; 4():72. PubMed ID: 17927817
    [Abstract] [Full Text] [Related]

  • 7. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A.
    Eur J Immunol; 1997 Aug 10; 27(8):1875-80. PubMed ID: 9295021
    [Abstract] [Full Text] [Related]

  • 8. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
    Cheent KS, Jamil KM, Cassidy S, Liu M, Mbiribindi B, Mulder A, Claas FH, Purbhoo MA, Khakoo SI.
    Proc Natl Acad Sci U S A; 2013 Oct 15; 110(42):16981-6. PubMed ID: 24082146
    [Abstract] [Full Text] [Related]

  • 9. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG, Borrego F, Posch PE, Patamawenu A, Scorzelli CJ, Ulbrecht M, Weiss EH, Coligan JE.
    J Immunol; 1999 Jan 01; 162(1):305-13. PubMed ID: 9886400
    [Abstract] [Full Text] [Related]

  • 10. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
    Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M, Geraghty DE.
    Proc Natl Acad Sci U S A; 1998 Apr 28; 95(9):5199-204. PubMed ID: 9560253
    [Abstract] [Full Text] [Related]

  • 11. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
    Pietra G, Romagnani C, Moretta L, Mingari MC.
    Curr Pharm Des; 2009 Apr 28; 15(28):3336-44. PubMed ID: 19860683
    [Abstract] [Full Text] [Related]

  • 12. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.
    Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J.
    Clin Exp Immunol; 2013 Dec 28; 174(3):414-23. PubMed ID: 23952339
    [Abstract] [Full Text] [Related]

  • 13. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.
    Fertil Steril; 2008 May 28; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [Abstract] [Full Text] [Related]

  • 14. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L.
    Proc Natl Acad Sci U S A; 1998 Feb 03; 95(3):1172-7. PubMed ID: 9448304
    [Abstract] [Full Text] [Related]

  • 15. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J, Park JS, Nam JH, Bang D, Sohn S, Lee ES, Park KS.
    Tissue Antigens; 2007 Oct 03; 70(4):307-13. PubMed ID: 17767552
    [Abstract] [Full Text] [Related]

  • 16. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H, Brahmi Z.
    Cell Immunol; 2002 Sep 03; 219(1):57-70. PubMed ID: 12473268
    [Abstract] [Full Text] [Related]

  • 17. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
    Hò GT, Celik AA, Huyton T, Hiemisch W, Blasczyk R, Simper GS, Bade-Doeding C.
    Int J Mol Sci; 2020 Jun 19; 21(12):. PubMed ID: 32575403
    [Abstract] [Full Text] [Related]

  • 18. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
    Michaëlsson J, Teixeira de Matos C, Achour A, Lanier LL, Kärre K, Söderström K.
    J Exp Med; 2002 Dec 02; 196(11):1403-14. PubMed ID: 12461076
    [Abstract] [Full Text] [Related]

  • 19. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M, Lee N, Navarro F, García P, Albar JP, Geraghty DE, López-Botet M.
    Eur J Immunol; 1998 Sep 02; 28(9):2854-63. PubMed ID: 9754572
    [Abstract] [Full Text] [Related]

  • 20. Structural basis for NKG2A/CD94 recognition of HLA-E.
    Kaiser BK, Pizarro JC, Kerns J, Strong RK.
    Proc Natl Acad Sci U S A; 2008 May 06; 105(18):6696-701. PubMed ID: 18448674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.